BrainStorm Cell Therapeutics
BCLI
#10513
Rank
HK$59.61 M
Marketcap
HK$5.40
Share price
-1.43%
Change (1 day)
-47.62%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -HK$84.54 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$91 Million, an increase over its 2023 earnings that were of -HK$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$84.54 Million-7.1%
2024 -HK$91 Million-32.39%
2023 -HK$0.14 Billion-29.18%
2022 -HK$0.2 Billion-0.74%
2021 -HK$0.2 Billion-23.12%
2020 -HK$0.25 Billion36.8%
2019 -HK$0.19 Billion66.71%
2018 -HK$0.11 Billion181.66%
2017 -HK$38.78 Million-0.6%
2016 -HK$39.01 Million-41.31%
2015 -HK$66.46 Million-8.22%
2014 -HK$72.41 Million89.74%
2013 -HK$38.17 Million42.27%
2012 -HK$26.83 Million-12.45%
2011 -HK$30.64 Million63.04%
2010 -HK$18.8 Million35.52%
2009 -HK$13.87 Million-48.99%
2008 -HK$27.19 Million-44.39%
2007 -HK$48.89 Million
2005 -HK$25.32 Million-91.44%
2004 -HK$0.3 Billion94007.62%
2003 -HK$0.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
HK$12.70 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.70 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$6.19 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$6.5 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.16 B-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-HK$2.01 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA